CA-125 as a maternal serum marker for Down's syndrome in the first and second trimesters |
| |
Authors: | Dr C. K. Høgdall E. V. S. Høgdall J. Arends B. Nørgaard-Pedersen S. Smidt-Jensen S. O. Larsen |
| |
Affiliation: | 1. Department of Clinical Biochemistry, Statens Seruminstitut, Denmark;2. Department of Gynaecology and Obstetrics, Rigshospitalet. University of Copenhagen, Copenhagen. Denmark;3. Department of Biostatistics, Statens Seruminstitut, Denmark |
| |
Abstract: | CA-125, alpha-fetoprotein (AFP), and human chorionic gonadotropin (HCG) were determined in maternal serum in the first trimester from 14 women with a Down's syndrome fetus and 61 women with a healthy fetus. In the second trimester, 15 and 60 serum samples were determined from women with a Down's syndrome and a healthy fetus respectively. In both trimesters, maternal serum CA-125 was found to be elevated in Down's syndrome pregnancies compared with controls. Using discrimination functions, our preliminary results indicate that CA-125 is a better marker than AFP and HCG respectively for a Down's syndrome fetus in the first trimester and improves the detection rate in the second trimester. |
| |
Keywords: | Trisomy 21 Down's syndrome Fetal markers CA-125 Alpha-fetoprotein Human chorionic gonadotropin |
|
|